FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023461305> ?p ?o ?g. }

• W2023461305 endingPage "8" @default.
• W2023461305 startingPage "1" @default.
• W2023461305 abstract "Objectives . The purpose of this retrospective evaluation of advanced-stage ovarian cancer patients was to compare outcome with published findings from other centers and to discuss future options for the management of advanced ovarian carcinoma patients. Methods . A retrospective series of 340 patients with a mean age of 58 years (range: 17–88) treated for FIGO stage III and IV ovarian cancer between January 1985 and January 2005 was reviewed. All patients had primary cytoreductive surgery, without extensive bowel, peritoneal, or systematic lymph node resection, thereby allowing initiation of chemotherapy without delay. Chemotherapy consisted of cisplatin-based chemotherapy in combination with alkylating agents before 2000, whereas carboplatin and paclitaxel regimes were generally used after 1999-2000. Overall survival and disease-free survival were analyzed by the Kaplan-Meier method and the log-rank test. Results . With a mean followup of 101 months (range: 5 to 203), 280 events (recurrence or death) were observed and 245 patients (72%) had died. The mortality and morbidity related to surgery were low. The main prognostic factor for overall survival was postoperative residual disease (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML><mml:mrow><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn>.0002</mml:mn></mml:mrow></mml:math>), while the main prognostic factor for disease-free survival was histological tumor type (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML><mml:mrow><mml:mi>P</mml:mi><mml:mo><</mml:mo><mml:mn>.0007</mml:mn></mml:mrow></mml:math>). Multivariate analysis identified three significant risk factors: optimal surgery (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML><mml:mrow><mml:mtext>RR</mml:mtext><mml:mo>=</mml:mo><mml:mn>2.2</mml:mn></mml:mrow></mml:math>for suboptimal surgery), menopausal status (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML><mml:mrow><mml:mtext>RR</mml:mtext><mml:mo>=</mml:mo><mml:mn>1.47</mml:mn></mml:mrow></mml:math>for postmenopausal women), and presence of a taxane in the chemotherapy combination (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML><mml:mrow><mml:mtext>RR</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.72</mml:mn></mml:mrow></mml:math>). Conclusion . These results confirm that optimal surgery defined by an appropriate and comprehensive effort at upfront cytoreduction limits morbidity related to the surgical procedure and allows initiation of chemotherapy without any negative impact on survival. The impact of neoadjuvant chemotherapy to improve resectability while lowering the morbidity of the surgical procedure is discussed." @default.
• W2023461305 created "2016-06-24" @default.
• W2023461305 creator A5006419895 @default.
• W2023461305 creator A5015020497 @default.
• W2023461305 creator A5022004459 @default.
• W2023461305 creator A5028630369 @default.
• W2023461305 creator A5034058277 @default.
• W2023461305 creator A5036029134 @default.
• W2023461305 creator A5053217861 @default.
• W2023461305 creator A5068413883 @default.
• W2023461305 creator A5074240671 @default.
• W2023461305 creator A5076097276 @default.
• W2023461305 creator A5085149517 @default.
• W2023461305 creator A5085752463 @default.
• W2023461305 creator A5088662395 @default.
• W2023461305 creator A5090374532 @default.
• W2023461305 date "2010-01-01" @default.
• W2023461305 modified "2023-09-27" @default.
• W2023461305 title "Outcome in Advanced Ovarian Cancer following an Appropriate and Comprehensive Effort at Upfront Cytoreduction: A Twenty-Year Experience in a Single Cancer Institute" @default.
• W2023461305 cites W1965111455 @default.
• W2023461305 cites W1965155043 @default.
• W2023461305 cites W1973703018 @default.
• W2023461305 cites W1975216695 @default.
• W2023461305 cites W1975428733 @default.
• W2023461305 cites W1977017190 @default.
• W2023461305 cites W1996384497 @default.
• W2023461305 cites W1998606142 @default.
• W2023461305 cites W2009028202 @default.
• W2023461305 cites W2009331070 @default.
• W2023461305 cites W2017697346 @default.
• W2023461305 cites W2025016389 @default.
• W2023461305 cites W2027862395 @default.
• W2023461305 cites W2035954087 @default.
• W2023461305 cites W2051320284 @default.
• W2023461305 cites W2055272681 @default.
• W2023461305 cites W2055344345 @default.
• W2023461305 cites W2056092926 @default.
• W2023461305 cites W2071037301 @default.
• W2023461305 cites W2094051330 @default.
• W2023461305 cites W2098292010 @default.
• W2023461305 cites W2100030862 @default.
• W2023461305 cites W2129367955 @default.
• W2023461305 cites W2141648807 @default.
• W2023461305 cites W2142795777 @default.
• W2023461305 cites W2143506086 @default.
• W2023461305 cites W2147539392 @default.
• W2023461305 cites W2162795878 @default.
• W2023461305 cites W2316387016 @default.
• W2023461305 cites W2328421677 @default.
• W2023461305 cites W2330108826 @default.
• W2023461305 cites W4233920089 @default.
• W2023461305 doi "https://doi.org/10.1155/2010/214919" @default.
• W2023461305 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3265260" @default.
• W2023461305 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22312486" @default.
• W2023461305 hasPublicationYear "2010" @default.
• W2023461305 type Work @default.
• W2023461305 sameAs 2023461305 @default.
• W2023461305 citedByCount "8" @default.
• W2023461305 countsByYear W20234613052012 @default.
• W2023461305 countsByYear W20234613052014 @default.
• W2023461305 countsByYear W20234613052018 @default.
• W2023461305 countsByYear W20234613052021 @default.
• W2023461305 countsByYear W20234613052023 @default.
• W2023461305 crossrefType "journal-article" @default.
• W2023461305 hasAuthorship W2023461305A5006419895 @default.
• W2023461305 hasAuthorship W2023461305A5015020497 @default.
• W2023461305 hasAuthorship W2023461305A5022004459 @default.
• W2023461305 hasAuthorship W2023461305A5028630369 @default.
• W2023461305 hasAuthorship W2023461305A5034058277 @default.
• W2023461305 hasAuthorship W2023461305A5036029134 @default.
• W2023461305 hasAuthorship W2023461305A5053217861 @default.
• W2023461305 hasAuthorship W2023461305A5068413883 @default.
• W2023461305 hasAuthorship W2023461305A5074240671 @default.
• W2023461305 hasAuthorship W2023461305A5076097276 @default.
• W2023461305 hasAuthorship W2023461305A5085149517 @default.
• W2023461305 hasAuthorship W2023461305A5085752463 @default.
• W2023461305 hasAuthorship W2023461305A5088662395 @default.
• W2023461305 hasAuthorship W2023461305A5090374532 @default.
• W2023461305 hasBestOaLocation W20234613051 @default.
• W2023461305 hasConcept C11413529 @default.
• W2023461305 hasConcept C121608353 @default.
• W2023461305 hasConcept C126322002 @default.
• W2023461305 hasConcept C141071460 @default.
• W2023461305 hasConcept C143998085 @default.
• W2023461305 hasConcept C146357865 @default.
• W2023461305 hasConcept C151730666 @default.
• W2023461305 hasConcept C167135981 @default.
• W2023461305 hasConcept C2776694085 @default.
• W2023461305 hasConcept C2778239845 @default.
• W2023461305 hasConcept C2780427987 @default.
• W2023461305 hasConcept C2780849966 @default.
• W2023461305 hasConcept C2781451048 @default.
• W2023461305 hasConcept C41008148 @default.
• W2023461305 hasConcept C71924100 @default.
• W2023461305 hasConcept C86803240 @default.
• W2023461305 hasConceptScore W2023461305C11413529 @default.
• W2023461305 hasConceptScore W2023461305C121608353 @default.
• W2023461305 hasConceptScore W2023461305C126322002 @default.

• next